217 related articles for article (PubMed ID: 9500446)
1. Sporadic medulloblastomas contain oncogenic beta-catenin mutations.
Zurawel RH; Chiappa SA; Allen C; Raffel C
Cancer Res; 1998 Mar; 58(5):896-9. PubMed ID: 9500446
[TBL] [Abstract][Full Text] [Related]
2. Control of beta-catenin/Tcf-directed transcription in medulloblastoma.
Raffel C
Acta Paediatr Suppl; 2004 May; 93(445):12-6; discussion 16-7. PubMed ID: 15176713
[TBL] [Abstract][Full Text] [Related]
3. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
[TBL] [Abstract][Full Text] [Related]
4. APC mutations in sporadic medulloblastomas.
Huang H; Mahler-Araujo BM; Sankila A; Chimelli L; Yonekawa Y; Kleihues P; Ohgaki H
Am J Pathol; 2000 Feb; 156(2):433-7. PubMed ID: 10666372
[TBL] [Abstract][Full Text] [Related]
5. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y
Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940
[TBL] [Abstract][Full Text] [Related]
6. A beta-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of beta-catenin germline mutations in FAP patients.
Müller O; Nimmrich I; Finke U; Friedl W; Hoffmann I
Genes Chromosomes Cancer; 1998 May; 22(1):37-41. PubMed ID: 9591632
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
Hagen T; Vidal-Puig A
Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
[TBL] [Abstract][Full Text] [Related]
8. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis.
Torbenson M; Lee JH; Cruz-Correa M; Ravich W; Rastgar K; Abraham SC; Wu TT
Mod Pathol; 2002 Jul; 15(7):718-23. PubMed ID: 12118109
[TBL] [Abstract][Full Text] [Related]
9. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin mutation in carcinoma of the uterine endometrium.
Fukuchi T; Sakamoto M; Tsuda H; Maruyama K; Nozawa S; Hirohashi S
Cancer Res; 1998 Aug; 58(16):3526-8. PubMed ID: 9721853
[TBL] [Abstract][Full Text] [Related]
11. Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas.
Choi YW; Heath EI; Heitmiller R; Forastiere AA; Wu TT
Mod Pathol; 2000 Oct; 13(10):1055-9. PubMed ID: 11048797
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin mutations in sporadic fundic gland polyps.
Sekine S; Shibata T; Yamauchi Y; Nakanishi Y; Shimoda T; Sakamoto M; Hirohashi S
Virchows Arch; 2002 Apr; 440(4):381-6. PubMed ID: 11956818
[TBL] [Abstract][Full Text] [Related]
13. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
[TBL] [Abstract][Full Text] [Related]
14. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).
Tejpar S; Nollet F; Li C; Wunder JS; Michils G; dal Cin P; Van Cutsem E; Bapat B; van Roy F; Cassiman JJ; Alman BA
Oncogene; 1999 Nov; 18(47):6615-20. PubMed ID: 10597266
[TBL] [Abstract][Full Text] [Related]
15. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
Vortmeyer AO; Stavrou T; Selby D; Li G; Weil RJ; Park WS; Moon YW; Chandra R; Goldstein AM; Zhuang Z
Cancer; 1999 Jun; 85(12):2662-7. PubMed ID: 10375116
[TBL] [Abstract][Full Text] [Related]
16. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
17. Correlation of gamma-catenin expression with good prognosis in medulloblastomas.
Misaki K; Marukawa K; Hayashi Y; Fukusato T; Minamoto T; Hasegawa M; Yamashita J; Fujisawa H
J Neurosurg; 2005 Mar; 102(2 Suppl):197-206. PubMed ID: 16156230
[TBL] [Abstract][Full Text] [Related]
18. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.
Torbenson M; Lee JH; Choti M; Gage W; Abraham SC; Montgomery E; Boitnott J; Wu TT
Mod Pathol; 2002 Mar; 15(3):189-96. PubMed ID: 11904335
[TBL] [Abstract][Full Text] [Related]
19. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
Dahmen RP; Koch A; Denkhaus D; Tonn JC; Sörensen N; Berthold F; Behrens J; Birchmeier W; Wiestler OD; Pietsch T
Cancer Res; 2001 Oct; 61(19):7039-43. PubMed ID: 11585731
[TBL] [Abstract][Full Text] [Related]
20. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
Kishida M; Koyama S; Kishida S; Matsubara K; Nakashima S; Higano K; Takada R; Takada S; Kikuchi A
Oncogene; 1999 Jan; 18(4):979-85. PubMed ID: 10023673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
